Literature DB >> 16612112

Genetic variations and normal fetal growth.

D B Dunger1, C J Petry, K K Ong.   

Abstract

Size at birth is said to be a highly heritable trait, with an estimated 30-70% of the variability a result of genetics. Data from family studies may be confounded, however, by potential interactions between fetal genes and the maternal uterine environment. Overall, the maternal environment tends to restrain fetal growth, and this is most evident in first pregnancies. Restraint of fetal growth appears to be inherited through the maternal line. Potential genetic candidates include the mitochondrial DNA 16189 variant, and common variants of exclusively maternally expressed genes, such as H19, which have been associated with size at birth. Maternal blood glucose levels and blood pressure are also correlated with size at birth, but the degree to which these changes relate to genetic variation in the mother is unclear. Elegant studies in mouse knockout models and rare genetic variants in humans have highlighted the importance of insulin-like growth factor I (IGF-I), IGF-II, insulin and their respective receptors in determining fetal growth. However, data linking common variation in the genes that regulate these proteins and receptors with size at birth are few and inconsistent. Interestingly, common variation in the insulin gene (INS) variable number tandem repeats, which regulates the transcription of insulin and IGF-II, has been associated with size at birth, largely in second and subsequent pregnancies, where maternal restraint is least evident. This suggests that fetal genes, and in particular paternally expressed genes, may have significant effects on fetal growth during pregnancies where maternal restraint of fetal growth is less evident. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2006        PMID: 16612112     DOI: 10.1159/000091504

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  9 in total

1.  Fetal growth restriction: current perspectives.

Authors:  Marianna Faraci; Eliana Renda; Santo Monte; Fosca A F Di Prima; Oriana Valenti; Roberta De Domenico; Elsa Giorgio; Entela Hyseni
Journal:  J Prenat Med       Date:  2011-04

2.  Fetal growth is increased by maternal type 1 diabetes and HLA DR4-related gene interactions.

Authors:  M Hummel; S Marienfeld; M Huppmann; A Knopff; M Voigt; E Bonifacio; A-G Ziegler
Journal:  Diabetologia       Date:  2007-02-20       Impact factor: 10.122

3.  HFE gene variants modify the association between maternal lead burden and infant birthweight: a prospective birth cohort study in Mexico City, Mexico.

Authors:  David Cantonwine; Howard Hu; Martha Maria Téllez-Rojo; Brisa N Sánchez; Héctor Lamadrid-Figueroa; Adrienne S Ettinger; Adriana Mercado-García; Mauricio Hernández-Avila; Robert O Wright
Journal:  Environ Health       Date:  2010-07-26       Impact factor: 5.984

4.  Altered expression of the imprinted transcription factor PLAGL1 deregulates a network of genes in the human IUGR placenta.

Authors:  Isabel Iglesias-Platas; Alex Martin-Trujillo; Paolo Petazzi; Amy Guillaumet-Adkins; Manel Esteller; David Monk
Journal:  Hum Mol Genet       Date:  2014-07-03       Impact factor: 6.150

Review 5.  Molecular genetics of human growth hormone, insulin-like growth factors and their pathways in common disease.

Authors:  Santiago Rodriguez; Tom R Gaunt; Ian N M Day
Journal:  Hum Genet       Date:  2007-05-30       Impact factor: 4.132

Review 6.  Defining normal and abnormal fetal growth: promises and challenges.

Authors:  Jun Zhang; Mario Merialdi; Lawrence D Platt; Michael S Kramer
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

7.  The Peter Pan paradigm.

Authors:  J Craig Cohen; Janet E Larson
Journal:  Theor Biol Med Model       Date:  2008-01-08       Impact factor: 2.432

8.  Genetic variant in the IGF2BP2 gene may interact with fetal malnutrition to affect glucose metabolism.

Authors:  Mandy van Hoek; Janneke G Langendonk; Susanne R de Rooij; Eric J G Sijbrands; Tessa J Roseboom
Journal:  Diabetes       Date:  2009-03-03       Impact factor: 9.461

9.  Factors affecting IGF-I level and correlation with growth response during growth hormone treatment in LG Growth Study.

Authors:  Ji Hyun Kim; Su Jin Kim; Jieun Lee; Choong Ho Shin; Ji-Young Seo
Journal:  PLoS One       Date:  2021-07-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.